iBio (IBIO) Amortizatization of Intangibles (2019 - 2025)
iBio's (IBIO) quarterly Amortizatization of Intangibles came in at $9000.0 in Q3 2025, down 86.76% year-on-year from $68000.0 in Q3 2024, and down 96.68% on a QoQ basis from $271000.0 in Q2 2025.
iBio (IBIO) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
iBio (IBIO) has 7 years of Amortizatization of Intangibles data on file, last reported at $9000.0 in Q3 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 86.76% year-over-year to $9000.0 in Q3 2025; TTM through Mar 2026 was $280000.0, a 2.94% increase from a year earlier, with the FY2025 full-year figure at $271000.0, changed 0.0% from the prior year.
- Amortizatization of Intangibles for Q3 2025 stood at $9000.0, down from $271000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for IBIO reached as high as $415000.0 in Q2 2021 and fell as low as -$275000.0 in Q2 2022.
- Historically, Amortizatization of Intangibles has averaged $80368.4 across 5 years, with a median of $68000.0 in 2023.
- Across the five-year window, Amortizatization of Intangibles tumbled 166.27% in 2022 and jumped 857.14% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $93000.0 in 2021, then slumped by 72.04% to $26000.0 in 2022, then surged by 161.54% to $68000.0 in 2023, then changed by 0.0% to $68000.0 in 2024, then slumped by 86.76% to $9000.0 in 2025.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $9000.0 in Q3 2025, $271000.0 in Q2 2025, and $68000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 271,000.00 |
| Jun 30, 2025 | 271,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Mar 31, 2025 | 68,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Dec 31, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 68,000.00 |
| Sep 30, 2023 | 68,000.00 |
| Jun 30, 2023 | -89,000.00 |
| Jun 30, 2023 | -89,000.00 |